Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Margarita L. Guenova, Gueorgui N. Balatzenko, Vessela R. Nikolova, Branimir V. Spassov & Spiro M. Konstantinov. (2010) An anti-apoptotic pattern correlates with multidrug resistance in acute myeloid leukemia patients: a comparative study of active caspase-3, cleaved PARPs, Bcl-2, Survivin and MDR1 gene. Hematology 15:3, pages 135-143.
Read now
Read now
J. Lyahyai, C. Serrano, B. Ranera, J. J. Badiola, P. Zaragoza & I. Martin-Burriel. (2009) Effect of Scrapie on the Stability of Housekeeping Genes. Animal Biotechnology 21:1, pages 1-13.
Read now
Read now
Birte Friedrichs, Sandra Siegel, Mads Hald Andersen, Norbert Schmitz & Matthias Zeis. (2006) Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies. Leukemia & Lymphoma 47:6, pages 978-985.
Read now
Read now
Articles from other publishers (23)
Yao Zhang, Yan Qian, Lu-xi Song, Chao Xiao & Chun-kang Chang. (2022) The use of carbon monoxide breath test to detect the effect of iron overload on erythrocyte lifespan in MDS. Frontiers in Oncology 12.
Crossref
Crossref
Stefan G. C. Mestrum, Anton H. N. Hopman, Frans C. S. Ramaekers & Math P. G. Leers. (2021) The potential of proliferative and apoptotic parameters in clinical flow cytometry of myeloid malignancies. Blood Advances 5:7, pages 2040-2052.
Crossref
Crossref
Xiaowen Liu, Zongliang Yue, Yimou Cao, Lauren Taylor, Qing Zhang, Sung W. Choi, Samir Hanash, Sawa Ito, Jake Y. Chen, Huanmei Wu & Sophie Paczesny. (2019) Graft-Versus-Host Disease–Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology. JCO Precision Oncology:3, pages 1-11.
Crossref
Crossref
Ghazala Khan, Kim Orchard & Barbara-ann Guinn. (2019) Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia. Journal of Clinical Medicine 8:2, pages 134.
Crossref
Crossref
Saskia MC Langemeijer, Niccolo Mariani, Ruth Knops, Christian Gilissen, Rob Woestenenk, Theo de Witte, Gerwin Huls, Bert A van der Reijden & Joop H Jansen. (2016) Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS Patients. PLOS ONE 11:11, pages e0165582.
Crossref
Crossref
R. Tibes, K. T. McDonagh, L. Lekakis, J. M. Bogenberger, S. Kim, N. Frazer, S. Mohrland, D. Bassett, R. Garcia, K. Schroeder, V. Shanmugam, J. Carpten, R. T. Hagelstrom, C. Beaudry, D. Von Hoff & T. C. Shea. (2014) Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias. Investigational New Drugs 33:2, pages 389-396.
Crossref
Crossref
Andrew S. Moore, Todd A. Alonzo, Robert B. Gerbing, Beverly J. Lange, Nyla A. Heerema, Janet Franklin, Susana C. Raimondi, Betsy A. Hirsch, Alan S. Gamis & Soheil Meshinchi. (2014)
BIRC5
(survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: A report from the Children's Oncology Group
. Pediatric Blood & Cancer 61:4, pages 647-652.
Crossref
Crossref
She-Hung Chan, Wohn-Jenn Leu, Lih-Ching Hsu, Hsun-Shuo Chang, Tsong-Long Hwang, Ih-Sheng Chen, Ching-Shih Chen & Jih-Hwa Guh. (2013) Reevesioside F induces potent and efficient anti-proliferative and apoptotic activities through Na+/K+-ATPase α3 subunit-involved mitochondrial stress and amplification of caspase cascades. Biochemical Pharmacology 86:11, pages 1564-1575.
Crossref
Crossref
Moshe Mittelman, Howard S. Oster, Michael Hoffman & Drorit Neumann. (2010) The lower risk MDS patient at risk of rapid progression. Leukemia Research 34:12, pages 1551-1555.
Crossref
Crossref
Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara, Shaw-Cheng Liu, Wee-Joo ChngKian-Ghee Tay, Lai-Fong Poon, Zhigang Xie, Senthilnathan Palaniyandi, Hanry YuKeith B. Glaser, Daniel H. Albert, Steven K. Davidsen & Chien-Shing Chen. (2009) Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML. Blood 113:17, pages 4052-4062.
Crossref
Crossref
Katharina Salome Minke, Peter Staib, Adriane Puetter, Iris Gehrke, Rajesh Kumar Gandhirajan, Axel Schlösser, Esther Katharina Schmitt, Michael Hallek & Karl-Anton Kreuzer. (2009) Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells. European Journal of Haematology 82:3, pages 165-175.
Crossref
Crossref
Ismael Samudio, Marina Konopleva, Bing Carter & Michael Andreeff. 2010. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia
197
217
.
Rosangela Invernizzi & Erica Travaglino. (2008) Increased Apoptosis as a Mechanism of Ineffective Erythropoiesis in Myelodysplastic Syndromes. Clinical Leukemia 2:2, pages 113-120.
Crossref
Crossref
Bing Z. Carter & Michael Andreeff. (2008) Targeting survivin in leukemia. Oncology Reviews 1:4, pages 195-204.
Crossref
Crossref
Olaf Hopfer, Martina Komor, Ina Sabine Koehler, Matthias Schulze, Dieter Hoelzer, Eckhard Thiel & Wolf-Karsten Hofmann. (2007) DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation. Experimental Hematology 35:5, pages 712-723.
Crossref
Crossref
Umberto Gianelli, Nicola Stefano Fracchiolla, Agostino Cortelezzi, Caterina Pellegrini, Federica Savi, Alessia Moro, Maria Grazia Grimoldi, Giorgio Lambertenghi Deliliers, Guido Coggi & Silvano Bosari. (2006) Survivin expression in “low-risk” and “high-risk” myelodysplastic syndromes. Annals of Hematology 86:3, pages 185-189.
Crossref
Crossref
Barbara-ann Guinn, Azim Mohamedali, Ken I. MillsBarbara Czepulkowski, Michael SchmittJochen Greiner. (2017) Leukemia Associated Antigens: Their Dual Role as Biomarkers and Immunotherapeutic Targets for Acute Myeloid Leukemia. Biomarker Insights 2, pages 117727190700200.
Crossref
Crossref
Jane E. Parker. 2007. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia
43
70
.
Edward A. Sausville. 2007. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia
231
246
.
Lijun Chen, Qiuyue Jin, Hong Xie, Ruimin Wang & Li Yao. (2006) Survivin antisense oligodeoxy-nucleotid induces apoptosis in leukaemia cell line K562. Chinese Journal of Clinical Oncology 3:6, pages 437-441.
Crossref
Crossref
Jason R. Fangusaro, Hugo Caldas, Yuying Jiang & Rachel A. Altura. (2006) Survivin: An inhibitor of apoptosis in pediatric cancer. Pediatric Blood & Cancer 47:1, pages 4-13.
Crossref
Crossref
Rosangela Invernizzi, Erica Travaglino, Chiara Benatti, Luca Malcovati, Matteo Della Porta, Mario Cazzola & Edoardo Ascari. (2006) Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia. European Journal of Haematology 76:6, pages 494-501.
Crossref
Crossref
Audrey Rousseau, Michèle Kujas, Anne-Marie Bergemer-Fouquet, Rémy van Effenterre & Jean-Jacques Hauw. (2005) Survivin expression in ganglioglioma. Journal of Neuro-Oncology 77:2, pages 153-159.
Crossref
Crossref